Insulin-like growth factor-binding proteins (IGFBPs) are important modulato
rs of IGF actions and may have both stimulatory and inhibitory effects. Exp
ression of IGFBP-2 is increased after fasting and in a variety of pathologi
cal conditions. However, the specific role of IGFBP-2 in growth physiology
remains to be determined. In this review, we summarize data from in vitro a
nd in vivo models suggesting that IGFBP-2 has mainly inhibitory effects on
IGF actions. Since the growth hormone (GH)/IGF system is involved in a numb
er of pathological alterations of the kidney and these changes may - at lea
st in part - be due to increased IGF-I, local overexpression of inhibitory
IGFBP-2 in the kidney might prevent IGF-I-induced lesions. This hypothesis
will be tested by crossing GH transgenic mice, a common model of glomerulos
clerosis, with transgenic mice characterized by systemic and renal overexpr
ession of IGFBP-2.